1 new stories
May
02nd
2026
1. Shift from Patents to Products Drives Biopharma Push at NIPER - The Policy Edge
Domain: policyedge.inA critical theme of the visit was the acceleration of translational research, with the need to move from “paper patents” to commercial products ...